Hal V. Barron
#26,967
Most Influential Person Now
American clinician-scientist
Hal V. Barron's AcademicInfluence.com Rankings
Hal V. Barronbiology Degrees
Biology
#4892
World Rank
#7237
Historical Rank
Immunology
#1055
World Rank
#1081
Historical Rank
Hal V. Barronphilosophy Degrees
Philosophy
#6152
World Rank
#9141
Historical Rank
Logic
#8353
World Rank
#10445
Historical Rank
Download Badge
Biology Philosophy
Why Is Hal V. Barron Influential?
(Suggest an Edit or Addition)According to Wikipedia, Hal V. Barron is an American clinician-scientist and drug developer who served as president of research and development at GlaxoSmithKline from March 2018 until 2022, when he resigned in order to join the cellular reprogramming venture Altos Labs in August of that year. Prior to this he served as president of research and development at Calico. He has served as executive vice president, head of global product development, and chief medical officer of Hoffman-La Roche.
Hal V. Barron's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sex-Based Differences in Early Mortality after Myocardial Infarction (1999) (1148)
- Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. (2000) (719)
- Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. (2005) (562)
- Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. (1999) (541)
- Autonomic nervous system and sudden cardiac death. (1996) (402)
- Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy (2000) (393)
- Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction (2002) (389)
- The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. (2000) (383)
- Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. (1998) (329)
- Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. (2000) (316)
- The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. (2001) (306)
- Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care: Observations From the National Registry of Myocardial Infarction 2 (2002) (264)
- Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. (2001) (250)
- Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction (1998) (229)
- Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study (2001) (204)
- The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project. (2001) (189)
- Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. (1996) (186)
- TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association With Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging (2002) (172)
- U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. (2005) (171)
- Predictors of door-to-balloon delay in primary angioplasty. (2002) (164)
- Mode of onset of torsade de pointes in congenital long QT syndrome. (1996) (149)
- Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. (2005) (148)
- Bundle-Branch Block and In-Hospital Mortality in Acute Myocardial Infarction (1998) (144)
- Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. (2003) (136)
- Relation Between Hospital Intra-Aortic Balloon Counterpulsation Volume and Mortality in Acute Myocardial Infarction Complicated by Cardiogenic Shock (2003) (133)
- A comparison of the national registry of myocardial infarction 2 with the cooperative cardiovascular project. (1999) (122)
- Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. (2001) (121)
- Treatment and outcome of myocardial infarction in hospitals with and without invasive capability (2000) (120)
- Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). (1998) (114)
- Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2. (2000) (114)
- Association of peripheral neutrophilia with adverse angiographic outcomes in ST-elevation myocardial infarction. (2004) (113)
- Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon. (2000) (110)
- Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent? (2000) (93)
- Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. (1986) (93)
- Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. (1998) (89)
- Smoking and mortality following acute myocardial infarction: results from the National Registry of Myocardial Infarction 2 (NRMI 2). (2002) (87)
- Ambulatory Electrocardiographic Evidence of Transmural Dispersion of Repolarization in Patients With Long-QT Syndrome Type 1 and 2 (2002) (83)
- Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. (2003) (73)
- TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma (2006) (72)
- Autonomic markers and prediction of cardiac death after myocardial infarction (1998) (71)
- Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. (2004) (71)
- The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. (2004) (71)
- Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. (1998) (66)
- Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction. The National Registry of Myocardial Infarction 2 Participants. (2000) (61)
- Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. (1998) (60)
- Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers? (1996) (56)
- Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA☆ (2002) (56)
- Hospital transfer of patients with acute myocardial infarction: the effects of age, race, and insurance type. (2002) (53)
- Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction. (2000) (46)
- β-Blocker Dosages and Mortality After Myocardial Infarction: Data From a Large Health Maintenance Organization (1998) (45)
- P-wave morphology during right atrial pacing before and after atrial flutter ablation--a new marker for success. (1997) (44)
- Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiography. (1997) (44)
- Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain (2000) (43)
- A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction. (2002) (42)
- Differentiation between LQT1 and LQT2 patients and unaffected subjects using 24-hour electrocardiographic recordings. (2002) (41)
- Relation of age and race with hospital death after acute myocardial infarction. (2004) (38)
- A1 adenosine receptors inhibit chloride transport in the shark rectal gland. Dissociation of inhibition and cyclic AMP. (1990) (37)
- Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. (2001) (35)
- Autonomic nervous system tone measured by baroreflex sensitivity is depressed in patients with end-stage liver disease (1999) (31)
- Vascular endothelial growth factors in pulmonary edema: an update (2008) (31)
- The association of sex and payer status on management and subsequent survival in acute myocardial infarction. (2002) (30)
- Methodologic and Clinical Validation of the TIMI Myocardial Perfusion Grade in Acute Myocardial Infarction (2002) (29)
- Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2. (2001) (28)
- Postextrasystolic U wave augmentation, a new marker of increased arrhythmic risk in patients without the long QT syndrome. (1996) (28)
- Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics. (2001) (27)
- Reperfusion therapy for acute myocardial infarction: observations from the National Registry of Myocardial Infarction 2. (1999) (26)
- Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction-2. (2000) (26)
- The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies. (2004) (25)
- Early use of ACE inhibitors in the treatment of acute myocardial infarction in the United States: experience from the National Registry of Myocardial Infarction 2. National Registry of Myocardial Infarction 2 participants. (1999) (25)
- Acute reperfusion therapy in ST-elevation myocardial infarction from 1994-2003. (2007) (25)
- Inhospital outcome of acute myocardial infarction in patients with prior coronary artery bypass surgery. (2002) (24)
- Use of Intra-aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (1998) (21)
- The treatment of atrial fibrillation: pharmacologic and nonpharmacologic strategies. (1997) (19)
- Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization. (1998) (17)
- Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial. (2001) (17)
- Comparison of outcomes research with clinical trials using preexisting data. (1999) (15)
- Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction. (2004) (15)
- Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris. (2000) (15)
- Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy. (2003) (15)
- Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. (2000) (15)
- Mortality benefit of implantable cardioverter-defibrillator therapy in patients with persistent malignant ventricular arrhythmias despite amiodarone treatment. (1997) (12)
- Early use of glycoprotein 2b3a inhibitors and outcomes in non-ST elevation MI: observations from the NRMI-4 (2002) (10)
- Time for contrast material to traverse the epicardial artery and the myocardium in ST-segment elevation acute myocardial infarction versus unstable angina pectoris/non-ST-elevation acute myocardial infarction. (2003) (9)
- A Comparison of intracranial hemorrhage rates in patients treated with rtPA and tPA-TNK: impact of gender, age and low body weight (1999) (9)
- Transforming quality of care and improving outcomes after acute MI: lessons from the National Registry of Myocardial Infarction. (2012) (8)
- Effect of beta-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: data from a large HMO. (1997) (8)
- Use of Reperfusion Therapies in Elderly Patients with Acute Myocardial Infarction (2001) (8)
- T-wave alternans and serious ventricular arrhythmias: a tale of two T-waves. (2000) (8)
- Precordial ST-Segment Depression in Inferior Myocardial Infarction is Associated with Slow Flow in the Non-Culprit Left Anterior Descending Artery (2002) (8)
- Prediction of Sudden Death after Myocardial Infarction: Value of Electrophysiologic Parameters (1997) (7)
- Racial differences in reperfusion therapy use in patients hospitalized with myocardial infarction: a regional phenomenon. (2005) (7)
- In-hospital outcome of acute myocardial infarction in patients with prior coronary artery bypass surgery: a study from NRMI 3 (2002) (6)
- Smoking and mortality following acute myocardial infarction: results from the national registry of myocardial infarction 2 (NRMI 2) (1998) (4)
- Access to patient-level trial data. (2014) (4)
- Internal Validity of AMI Databases: A Comparison of the NRMI-2 and CCP Databases (1998) (4)
- Use of Helicopter Transportation in Acute Myocardial Infarction in the United States (1998) (3)
- Silent Myocardial Ischemia and Infarction. 2nd Edition (1989) (3)
- Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value (2008) (3)
- Racial differences in acute reperfusion therapy use in patients hospitalized with acute myocardial infarction: A regional phenomenon (2003) (2)
- Reduction in Intracranial Hemorrhage Associated With Immediate Beta-Blocker Therapy in Patients With Acute Myocardial Infarction Treated With Tissue Plasminogen Activator (1998) (2)
- Acute Coronary Intervention (1988) (2)
- Prevention of cardiac arrest: risk assessment after myocardial infarction. (2002) (1)
- The Relationship of Intracoronary Stent Placement Following Thrombolytic Therapy to Tissue Level Perfusion (2002) (1)
- ICD use as a bridge to cardiac transplantation. (1996) (1)
- Regulating laboratory-developed tests (2009) (1)
- Therapeutic margin of safety with weight-optimized dosing of tenecteplase (2001) (1)
- b-Blocker Dosages and Mortality After Myocardial Infarction (2001) (1)
- Disparities in the treatment of acute myocardial infarction: Underutilization of evidence-based therapies for patients with non-ST-segment myocardial infarction (2003) (1)
- The effect of payer status on regional utilization of hospital resources in acute myocardial infarction (1998) (0)
- 302A ABSTRACTS- Myocardial Ischemia and Infarction (2016) (0)
- Options in antihypertensive drug therapy. Help in choosing from among the many agents. (1996) (0)
- Women and Payer Status in the United States: Utilization of Hospital Resources for Acute Myocardial Infarction (1998) (0)
- Congestive heart failure following liver transplantation: Echocardiographic predictors and response to therapy (1996) (0)
- Ischemic versus non-ischemic polymorphous ventricular tachycardia-differences in initiating sequences (1998) (0)
- An angiographic risk score integrating both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute MI (2002) (0)
- Quality improvement over time: hospital characteristics associated with increased usage of beta-blockers after myocardial infarction (2002) (0)
- Impact of left and right bundle branch block on in-hospital mortality in acute myocardial infarction (1998) (0)
- Glycoprotein IIb/IIIa inhibitors are underutilized among patients who undergo cardiac catheterization following acute myocardial infarction: Observations from the NRMI-4 (2003) (0)
- Electrocardiographic changes associated with the development of polymorphous ventricular tachycardia (1998) (0)
- Risk of major bleeding in patients treated with PTCA early following thrombolysis with TNK vs t-PA (2001) (0)
- Assessing the significance of preinfarction angina. (1996) (0)
- Myocardial perfusion and TIMI flow. (1997) (0)
- Gender Based Inequities Among Payer Groups in Hospital Resource Utilization for Acute Myocardial Infarction (1998) (0)
- Risk of serious bleeding events in AMI patients treated with TNK-tPA or rtPA (1999) (0)
- Drug Therapy in Dilated Cardiomyopathy and Myocarditis (1989) (0)
- Treatment center (TC) variability in survival of patients (pts) with colorectal cancer (mCRC) treated with bevacizumab (BV): A subanalysis from the BRiTE Observational Study (OCS). (2009) (0)
- 1135-67 Time trends in the treatment of women and men with acute myocardial infarction in the United States (2004) (0)
- General cardiologyAbstractRacial Differences in Reperfusion Therapy Use in Patients Hospitalized With Myocardial Infarction: A Regional Phenomenon (2005) (0)
- Temporal Trends in Underutilization of Reperfusion Therapy in Acute Myocardial Infarction-Data from the National Registry of Myocardial Infarction 2,3, and 4 [Poster] (2003) (0)
This paper list is powered by the following services:
Other Resources About Hal V. Barron
What Schools Are Affiliated With Hal V. Barron?
Hal V. Barron is affiliated with the following schools:
